Cargando…

Factors associated with recurrence and survival length following relapse in patients with neuroblastoma

BACKGROUND: Despite therapeutic advances, survival following relapse for neuroblastoma patients remains poor. We investigated clinical and biological factors associated with length of progression-free and overall survival following relapse in UK neuroblastoma patients. METHODS: All cases of relapsed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basta, Nermine O, Halliday, Gail C, Makin, Guy, Birch, Jillian, Feltbower, Richard, Bown, Nick, Elliott, Martin, Moreno, Lucas, Barone, Giuseppe, Pearson, Andrew DJ, James, Peter W, Tweddle, Deborah A, McNally, Richard JQ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117794/ https://www.ncbi.nlm.nih.gov/pubmed/27701387 http://dx.doi.org/10.1038/bjc.2016.302

Ejemplares similares

A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma
por: Herd, Fiona, et al.
Publicado: (2019)

Loss of ALK hotspot mutations in relapsed neuroblastoma
por: Allinson, Lisa M., et al.
Publicado: (2022)

Temporal clustering of neuroblastic tumours in children and young adults from Northern England
por: Muirhead, Colin R., et al.
Publicado: (2015)

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse
por: Chen, Lindi, et al.
Publicado: (2016)

Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada
por: Hayes, Louise, et al.
Publicado: (2022)

Space-time clustering of childhood central nervous system tumours in Yorkshire, UK
por: McNally, Richard JQ, et al.
Publicado: (2012)

The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002
por: Eyre, Rachel, et al.
Publicado: (2010)

Patterns of suicide deaths in Hungary between 1995 and 2017
por: Lantos, Tamás, et al.
Publicado: (2021)

Cross-space-time clustering of childhood cancer in Great Britain: Evidence for a common aetiology
por: McNally, Richard JQ, et al.
Publicado: (2014)

Space-time clustering analyses of type 1 diabetes in children from north-east England: support for an infectious aetiology?
por: McNally, Richard JQ, et al.
Publicado: (2009)

Katanin controls mitotic and meiotic spindle length
por: McNally, Karen, et al.
Publicado: (2006)

Individualized (131)I-mIBG therapy in the management of refractory and relapsed neuroblastoma
por: George, Sally L., et al.
Publicado: (2016)

Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0–49-year-olds in Great Britain, 1980–2005
por: Blakey, Karen, et al.
Publicado: (2014)

Novel Therapies for Relapsed and Refractory Neuroblastoma
por: Zage, Peter E.
Publicado: (2018)

Sex-specific incidence and temporal trends in solid tumours in young people from Northern England, 1968–2005
por: Magnanti, Brooke L, et al.
Publicado: (2008)

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

The Promises and Pitfalls of Retrieval-Extinction Procedures in Preventing Relapse to Drug Seeking
por: Hutton-Bedbrook, Kate, et al.
Publicado: (2013)

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
por: Schleiermacher, G, et al.
Publicado: (2011)

Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981–2018
por: Memon, Anjum, et al.
Publicado: (2021)

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
por: Padovan-Merhar, Olivia M., et al.
Publicado: (2016)

Targeting MYCN and ALK in resistant and relapsing neuroblastoma
por: Tucker, Elizabeth R, et al.
Publicado: (2019)

Genomic ALK alterations in primary and relapsed neuroblastoma
por: Rosswog, Carolina, et al.
Publicado: (2023)

Congenital Hypothyroidism: Space–Time Clustering of Thyroid Dysgenesis Indicates a Role for Environmental Factors in Disease Etiology
por: McNally, Richard J.Q., et al.
Publicado: (2021)

Neuroblastoma
por: Pearson, D.
Publicado: (1977)

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
por: Gamble, Laura D., et al.
Publicado: (2011)

Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma
por: Chen, L, et al.
Publicado: (2014)

Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma
por: Taylor, C P F, et al.
Publicado: (2000)

ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

Immune response to racotumomab in a child with relapsed neuroblastoma
por: Sampor, C., et al.
Publicado: (2012)

Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
por: Zhu, Jia, et al.
Publicado: (2022)

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
por: Decock, Anneleen, et al.
Publicado: (2015)

Fatal Borreliosis in Bat Caused by Relapsing Fever Spirochete, United Kingdom
por: Evans, Nicholas J., et al.
Publicado: (2009)

Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma
por: Barford, Ruby G., et al.
Publicado: (2023)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study
por: Pang, D, et al.
Publicado: (2003)

Intratumoral diversity of telomere length in individual neuroblastoma tumors
por: Pezzolo, Annalisa, et al.
Publicado: (2014)

Generation of evidence-based carboplatin dosing guidelines for neonates and infants
por: Barnett, Shelby, et al.
Publicado: (2023)

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
por: Bellini, Angela, et al.
Publicado: (2021)

The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse
por: Riehl, Lara M., et al.
Publicado: (2015)

Different Subcellular Localization of ALCAM Molecules in Neuroblastoma: Association with Relapse
por: Corrias, Maria Valeria, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_oqt7il6p7g956r0vvtno0i9s78